hydroxychloroquine antimalarial
Selected indexed studies
- Hydroxychloroquine: A double‑edged sword (Review). (Mol Med Rep, 2025) [PMID:39981928]
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. (Nat Rev Rheumatol, 2020) [PMID:32034323]
- Pregnancy and Systemic Lupus Erythematosus. (Best Pract Res Clin Obstet Gynaecol, 2020) [PMID:31677989]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hydroxychloroquine: A double‑edged sword (Review). (2025) pubmed
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. (2020) pubmed
- Pregnancy and Systemic Lupus Erythematosus. (2020) pubmed
- Mechanism of action of hydroxychloroquine as an antirheumatic drug. (1993) pubmed
- Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting. (2024) pubmed
- Artemisinin-hydroxychloroquine combination from traditional antimalarial medicine attenuates pulmonary fibrosis via PI3K/AKT/GSK3β-mediated inhibition of epithelial-mesenchymal transition. (2026) pubmed
- An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine. (2021) pubmed
- Antimalarials. (1981) pubmed
- Hydroxychloroquine and COVID-19. (2020) pubmed
- Attenuation of antimalarial agent hydroxychloroquine on TNF-α-induced endothelial inflammation. (2018) pubmed